XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Myriam J. Curet, M.D., F.A.C.S [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement On July 29, 2025, Myriam J. Curet, M.D., F.A.C.S., the Company’s Chief Medical Officer, adopted a Rule 10b5-1 trading plan. Dr. Curet’s trading plan provides for the potential sale of up to 24,003 shares of the Company’s common stock, including the potential exercise and sale of up to 9,131 shares of the Company’s common stock subject to stock options, until July 29, 2026. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities
Name Myriam J. Curet, M.D., F.A.C.S.
Rule 10b5-1 Arrangement Adopted true
Adoption Date July 29, 2025
Expiration Date July 29, 2026
Arrangement Duration 365 days
Mark P. Brosius [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On September 12, 2025, Mark P. Brosius, the Company’s Chief Manufacturing and Supply Chain Officer, adopted a Rule 10b5-1 trading plan. Mr. Brosius’s trading plan provides for the potential sale of up to 19,730 shares of the Company’s common stock, including the potential exercise and sale of up to 9,000 shares of the Company’s common stock subject to stock options, until February 14, 2027. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Mark P. Brosius
Title Chief Manufacturing and Supply Chain Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date September 12, 2025
Expiration Date February 14, 2027
Arrangement Duration 520 days
Myriam J. Curet Trading Arrangement, Common Stock [Member] | Myriam J. Curet, M.D., F.A.C.S [Member]  
Trading Arrangements, by Individual  
Aggregate Available 24,003
Myriam J. Curet Trading Arrangement, Stock Options [Member] | Myriam J. Curet, M.D., F.A.C.S [Member]  
Trading Arrangements, by Individual  
Aggregate Available 9,131
Mark P. Brosius Trading Arrangement, Common Stock [Member] | Mark P. Brosius [Member]  
Trading Arrangements, by Individual  
Aggregate Available 19,730
Mark P. Brosius Trading Arrangement, Stock Options [Member] | Mark P. Brosius [Member]  
Trading Arrangements, by Individual  
Aggregate Available 9,000